ROUNDUP 2: EMA clears the way for two new Covid drugs

Thursday, 11/11/2021 6:56 PM from


| Views: 34

Medicines in tablet form (symbolic image). ©

(Information on medication added)

AMSTERDAM (dpa-AFX) – The European Medicines Agency EMA has cleared the way for the approval of two new drugs against Covid-19. It is about the antibody therapy Ronapreve from the Swiss pharmaceutical company Roche and the drug Regkirona (Regdanvimab) from the manufacturer Celltrion from South Korea. The EMA announced on Thursday in Amsterdam. Both drugs are intended to be used in the early stages of infection and are based on antiviral monoclonal antibodies.


Further up?

Short-term position in Regeneron Pharmaceuticals

Ask: 10,61

Leverage: 5.11

with moderate leverage

HSBC Trinkaus & Burkhardt AG

The base prospectus as well as the final terms and the key information sheets are available here: TT7NRC,. Also note the further notes to this advertisement. The issuer is entitled to terminate securities with an open-end term. You can find license information here.


Subscribe to more news about the knock-out (NASDAQOTH: VQ9F70) for free

ARIVA.DE publishes analyzes, columns and news from various sources in this section. ARIVA.DE AG is not responsible for content that is recognizably posted by third parties in the “News” area of ​​this website and does not adopt it as its own. This content can be identified in particular by a corresponding “from” label below the article heading and / or by the link “To read the full article, please click here.”; The named third party is solely responsible for this content.

Other users were also interested in this article:

Leave A Comment